Kindlin-2 inhibits Nlrp3 inflammasome activation in nucleus pulposus to maintain homeostasis of the intervertebral disc

被引:0
|
作者
Sheng Chen
Xiaohao Wu
Yumei Lai
Di Chen
Xiaochun Bai
Sheng Liu
Yongchao Wu
Mingjue Chen
Yuxiao Lai
Huiling Cao
Zengwu Shao
Guozhi Xiao
机构
[1] Huazhong University of Science and Technology,Department of Orthopaedics, Union Hospital, Tongji Medical College
[2] Shenzhen Key Laboratory of Cell Microenvironment,Department of Biochemistry, School of Medicine, Southern University of Science and Technology, Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research
[3] Rush University Medical Center,Department of Orthopedic Surgery
[4] Chinese Academy of Sciences,Research Center for Human Tissues and Organs Degeneration, Shenzhen Institutes of Advanced Technology
[5] Southern Medical University,Department of Cell Biology, School of Basic Medical Sciences
[6] Chinese Academy of Sciences,Centre for Translational Medicine Research and Development, Institute of Biomedical and Health Engineering, Shenzhen Institute of Advanced Technology
来源
Bone Research | / 10卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Intervertebral disc (IVD) degeneration (IVDD) is the main cause of low back pain with major social and economic burdens; however, its underlying molecular mechanisms remain poorly defined. Here we show that the focal adhesion protein Kindlin-2 is highly expressed in the nucleus pulposus (NP), but not in the anulus fibrosus and the cartilaginous endplates, in the IVD tissues. Expression of Kindlin-2 is drastically decreased in NP cells in aged mice and severe IVDD patients. Inducible deletion of Kindlin-2 in NP cells in adult mice causes spontaneous and striking IVDD-like phenotypes in lumbar IVDs and largely accelerates progression of coccygeal IVDD in the presence of abnormal mechanical stress. Kindlin-2 loss activates Nlrp3 inflammasome and stimulates expression of IL-1β in NP cells, which in turn downregulates Kindlin-2. This vicious cycle promotes extracellular matrix (ECM) catabolism and NP cell apoptosis. Furthermore, abnormal mechanical stress reduces expression of Kindlin-2, which exacerbates Nlrp3 inflammasome activation, cell apoptosis, and ECM catabolism in NP cells caused by Kindlin-2 deficiency. In vivo blocking Nlrp3 inflammasome activation prevents IVDD progression induced by Kindlin-2 loss and abnormal mechanical stress. Of translational significance, adeno-associated virus-mediated overexpression of Kindlin-2 inhibits ECM catabolism and cell apoptosis in primary human NP cells in vitro and alleviates coccygeal IVDD progression caused by mechanical stress in rat. Collectively, we establish critical roles of Kindlin-2 in inhibiting Nlrp3 inflammasome activation and maintaining integrity of the IVD homeostasis and define a novel target for the prevention and treatment of IVDD.
引用
收藏
相关论文
共 50 条
  • [21] SOX4 accelerates intervertebral disc degeneration via EZH2/NRF2 pathway in response to mitochondrial ROS-dependent NLRP3 inflammasome activation in nucleus pulposus cells
    Zhao, Wenzhi
    Liu, Yadong
    Hu, Yunxiang
    Zhang, Guiqi
    JOURNAL OF TRANSLATIONAL MEDICINE, 2025, 23 (01)
  • [22] Fluoxetine Inhibits NLRP3 Inflammasome Activation: Implication in Depression
    Du, Ren-Hong
    Tan, Jun
    Sun, Xi-Yang
    Lu, Ming
    Ding, Jian-Hua
    Hu, Gang
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 (09): : 1 - 9
  • [23] Andrographolide inhibits the activation of NLRP3 inflammasome in patients with COPD
    Xiao, Wei
    Fu, Juan-Juan
    Wang, Sheng-Jun
    Wang, Yan
    Miao, Ti-Wei
    Mao, Bing
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [24] Ion homeostasis and ion channels in NLRP3 inflammasome activation and regulation
    Hafner-Bratkovic, Iva
    Pelegrin, Pablo
    CURRENT OPINION IN IMMUNOLOGY, 2018, 52 : 8 - 17
  • [25] The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation
    Hooftman, Alexander
    Angiari, Stefano
    Hester, Svenja
    Corcoran, Sarah E.
    Runtsch, Marah C.
    Ling, Chris
    Ruzek, Melanie C.
    Slivka, Peter F.
    McGettrick, Anne F.
    Banahan, Kathy
    Hughes, Mark M.
    Irvine, Alan D.
    Fischer, Roman
    O'Neill, Luke A. J.
    CELL METABOLISM, 2020, 32 (03) : 468 - +
  • [26] Safranal inhibits NLRP3 inflammasome activation by preventing ASC oligomerization
    Gupta, Mehak
    Wani, Abubakar
    Ahsan, Aitizaz Ul
    Ali, Mehboob
    Chibber, Pankaj
    Singh, Surjeet
    Digra, Sanjeev K.
    Datt, Manish
    Bharate, Sandip B.
    Vishwakarma, Ram A.
    Singh, Gurdarshan
    Kumar, Ajay
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2021, 423
  • [27] Investigating how the immunosuppressant cyclosporin A inhibits NLRP3 inflammasome activation
    Vijayaraj, Swarna Lekha
    CYTOKINE, 2014, 70 (01) : 74 - 74
  • [28] Isoandrographolide inhibits NLRP3 inflammasome activation and attenuates silicosis in mice
    Song, Zhe
    Wang, Li
    Cao, Yongxia
    Liu, Zihan
    Zhang, Mingliang
    Zhang, Zhizi
    Jiang, Shan
    Fan, Ruifeng
    Hao, Ting
    Yang, Ruyue
    Wang, Bingshun
    Guan, Zhenzhen
    Zhu, Lina
    Liu, Zhentao
    Zhang, Shuya
    Zhao, Liang
    Xu, Zhihao
    Xu, Haiwei
    Dai, Guifu
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 105
  • [29] Resveratrol ameliorates hepatic metaflammation and inhibits NLRP3 inflammasome activation
    Yang, Soo Jin
    Lim, Yunsook
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2014, 63 (05): : 693 - 701
  • [30] Posttreatment of Maresin1 Inhibits NLRP3 inflammasome activation via promotion of NLRP3 ubiquitination
    Zheng, Sisi
    Ma, Minqi
    Li, Zhongwang
    Hao, Yu
    Li, Hui
    Fu, Panhan
    Jin, Shengwei
    FASEB JOURNAL, 2020, 34 (09): : 11944 - 11956